Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$137,409,009
+$35,679,415 QoQ
Shares Held
2,450,669
+15.6% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#31
of 646 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. RPRX ranks #3 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in RPRX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,409,009 | 2,450,669 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $101,729,594 | 2,120,692 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $15,329,955 | 396,738 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $52,344,088 | 1,483,676 | Shares | Other | 2025-11-13 | |
| 2024-06-30 | $24,941,800 | 945,840 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $44,215,683 | 1,455,900 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $40,450,807 | 1,440,043 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $4,472,943 | 164,810 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $55,535,529 | 1,806,621 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $24,231,255 | 672,530 | Shares | Other | 2023-05-15 | |
| 2022-09-30 | $17,367,805 | 432,250 | Shares | Other | 2022-11-14 | |
| 2022-03-31 | $2,908,558 | 74,655 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $7,605,213 | 190,846 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $43,439,557 | 1,201,980 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 | $1,230,757 | 29,255 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||